Marketing disclosures are often treated as the final step in a product launch. A disclaimer is added, compliance signs off, the campaign goes live, and attention moves elsewhere. The Malta Financial Services Authority's latest supervisory review suggests that approach remains more common than regulators would like.
Brazil's antitrust authority has fined Japanese automotive supplier Denso Corporation approximately $19.5 million (100.8 million reais), concluding a case that traces back more than a decade and centers on allegations of coordinated conduct in the market for wire harnesses and other automotive electrical components.
The Italian Competition Authority has fined Philip Morris €7 million after finding that the company's advertising for combustion-free tobacco products misled consumers into believing the products were harmless to health or less harmful than other tobacco products.
A discount program is supposed to lower the price of a prescription. The dispute at the center of a newly announced $40 million settlement is what happens when those discounts exist for customers but are not reflected in the prices reported to government healthcare programs.
A Florida-based commercial lender has agreed to pay a $4 million penalty and provide refunds to California borrowers after state regulators found the company engaged in lending activities without the required license, according to an enforcement action announced Monday by the California Department of Financial Protection and Innovation (DFPI).
Broadway Electric and Cornerstone Contracting, two New York-based government contractors, along with its CEO and President, have agreed to pay $21.3 million to resolve allegations that they used service-disabled veteran-owned small businesses and other qualifying firms as vehicles to secure federal contracts that otherwise would have been out of reach.
A decade-long practice involving insulin prescriptions has led CVS Pharmacy to agree to pay $36.5 million to resolve allegations that it improperly billed Medicaid programs across the United States for more insulin than patients were prescribed.